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Abstract 
Expression of the type Ill antifreeze protein (AFP) gene from ocean 
pout (OP5a) was examined in ocean pout and Atlantic salmon transgenic for 
a truncated version this gene (t-OP5a). Also, Atlantic salmon transgenic for 
an "all-fish chimeric gene construct" composed of the ocean pout type Ill AFP 
gene 5' and 3' ends linked to the Chinook salmon growth hormone (GH) gene 
(E0-1a) was examined for GH mRNA. Northern blot analysis of ocean pout 
demonstrated that AFP mRNA was detected in most tissues with extremely 
high levels observed in the liver, and high levels in the stomach and gill. Low 
AFP mRNA levels were observed in skin, mouth skin, intestine, spleen, and 
kidney, while barely detectable levels were observed in heart, ovary, brain, 
and blood cells. No AFP mRNA was observed in muscle. For t-OP5a 
transgenic Atlantic salmon, AFP mRNA was detected in most tissues with 
high levels observed in heart, liver, stomach, and brain, low levels observed 
in mouth skin, intestine, spleen, gill, and muscle, and barely detectable levels 
observed in kidney, ovary and skin. No AFP mRNA was observed in blood 
cells. Northern blot analysis of E0-1 a transgenic salmon demonstrated that 
expression was observed only in pituitary and spleen, with moderate 
expression detected in the pituitary and low expression in the spleen. 
Reverse transcription polymerase chain reaction (RT-PCR) demonstrated that 
the OP5a gene is expressed in all tissues of the ocean pout, and all tissues 
except for blood in both transgenic Atlantic salmon lines (t-OP5a and E0-1a). 
Blood plasma samples from the three strains of fish were tested for AFP 
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activity by determining the thermal hysteresis (TH) for each. TH 
measurements from winter acclimated ocean pout were high (approximately 
1.36°C) with typical bipyrimidal ice crystal shaping indicative of a high amount 
of AFP, while t-OP5a transgenic fish showed little(< 0.01°C) TH activity, but 
yielded hexagonal shaped ice crystals indicative of the presence of AFP. On 
the other hand, E0-1a transgenics showed no (0°C) TH activity and no ice 
crystal shaping, as expected. The differences observed in the level of 
expression between ocean pout and the two transgenic fish lines may be 
attributed to gene copy number, where it is high in ocean pout and low in 
transgenic salmon, and promoter integrity, where the promoter is intact in 
ocean pout and truncated in both transgenic lines. In addition, differences in 
expression levels between the two transgenic lines may be a result of the 
presence or absence of intervening sequences (introns) in the DNA where the 
t-OP5a construct contains introns while the E0-1 a construct does not. Finally, 
it is apparent by its ubiquitous expression in transgenic Atlantic salmon that, 
unlike the type I AFP from winter flounder, the introns within the ocean pout 
OP5a AFP gene do not contain tissue specific elements, or salmon lack the 
factors needed to recognize them. 
iii 
Acknowledgements 
I gratefully thank Dr. Garth Fletcher for his invitation to join his 
laboratory, as well as providing support both academically and financially 
throughout the project. His continual advice and guidance along with his 
tireless work ethic have set an excellent example. I also thank the members 
of my supervisory committee, Dr. Murray Colbo and Dr. William Driedzic. 
I thank members of the lab, including Ann Angel, Chris Dawe and John 
Evely for their help in fish identification and handling. I also thank Tracy 
Granter for her assistance with thermal hysteresis measurements. I especially 
thank Dr.'s Margaret Shears, Robert Evans, and Seumas Walker and 
Madonna King for their constant guidance and assistance in many laboratory 
techniques. 
The involvement of many other people in this work is gratefully 
acknowledged. Members of Dr. Driedzic's lab, especially Jennifer Hall, have 
shared extensive technical expertise. Similarly, members of Dr. Peter Davies' 
lab (Queens University), particularly Dr. Melanie Tomczak and Sherry 
Gauthier, have provided steady guidance and insight into the technique for 
thermal hysteresis measurements. 
Additional financial support from Aquanet, and the Special Scholarship 
for students to Pursue Graduate Studies Related to Resource Development is 
greatly acknowledged. 
Finally, I thank my family, friends and Virginia for their constant support 
and encouragement. 
IV 
Table of Contents 
ABSTRACT .......................................................................................................... II 
ACKNOWLEDGEMENTS ................................................................................. IV 
LIST OF TABLES ............................................................................................. VII 
LIST OF FIGURES .......................................................................................... VIII 
1. INTRODUCTION ............................................................................................. 1 
1 .1 GENERAL ...................................................................................................... 1 
1 .2 OCEAN POUT ................................................................................................ 5 
2. MATERIALS AND METHODS ..................................................................... 1 0 
2.1. EXPERIMENTAL ANIMALS ............................................................................ 10 
2.2. TISSUE SAMPLING .................... ................................................................... 15 
2.3. RNA ISOLATION ......................................................................................... 16 
2.4. PROBE PRODUCTION .................................................................................. 17 
2.4.1. Bacterial Preparation ......................................................................... 17 
2.4.2. Small-Scale Plasmid Purification ...................................................... 18 
2.4.3. Large-Scale Plasmid Purification ...................................................... 19 
2.4.4. DIG-RNA Labelling ............................................................................ 21 
2.5. NORTHERN BLOT ANALYSIS ......................................................................... 22 
2.6. REVERSE TRANSCRIPTION (Rn .................................................................. 25 
2.7. POLYMERASE CHAIN REACTION (PCR) ....................................................... 26 
2.8. AGAROSE GEL ELECTROPHORESIS ............................................................. 30 
2.9. DNA SEQUENCING ..................................................................................... 30 
2.1 0. THERMAL HYSTERESIS MEASUREMENTS ................................................... 31 
v 
3. RESULTS ................................................... ............... ........... ... ......... ........ 33 
3.1. EXPRESSION OF THE 0P5a AFP GENE IN OCEAN POUT ............................. 33 
3.2. EXPRESSION OF THE t-0P5a GENE CONSTRUCT IN TRANSGENIC ATLANTIC 
SALMON ....................................................................................................... 39 
3 .3. EXPRESSION OF THE E0-1a GENE CONSTRUCT IN TRANSGENIC ATLANTIC 
SALMON ....................................................................................................... 44 
3.4. THERMAL HYSTERESIS ............................................................................ 4 7 
4. DISCUSSION ... ............... ................. ........... ...... ....... .................... ............. 54 
5. REFERENCES .................................................. ............. ...... ... .................. 62 
vi 
List of Tables 
1. Characteristics of transgenic fish used in RT -PCR and Northern 
analyses .. . ..................................... .. ..... .. ... ... .... . .... ... ........ ..... ..... ... 11 
2. Primer pairs used for polymerase chain reaction and their annealing 
sites ................................ . ......... ...... . .. .... ... .. .... .. .. . .......... ..... ...... 27 
3. Plasma thermal hysteresis measurements taken from ocean pout and 
transgenic Atlantic salmon ............... ...................... .. .. .. ....... .. ........ .. 50 
vii 
List of Figures 
1. Structure of the ocean pout type Ill AFP gene (OP5a) ....................... 7 
2. Structure of the truncated ocean pout AFP gene injected into Atlantic 
salmon eggs to produce t-OP5a transgenic Atlantic salmon .................. 12 
3. Structure of the "all fish chimeric gene construct" (opAFP-GHc2) 
injected into Atlantic salmon eggs producing E0-1 a transgenic Atlantic 
salmon ....................................................................................... 13 
4. Schematic of the proposed structure of the E0-1 a construct in 
transgenic Atlantic salmon ............ .... ... ....................... .................... 14 
5. Northern blot analysis of ocean pout total RNA from various tissues 
as seen on a formaldehyde agarose gel. .................. ....... .. ................ 34 
6. RT-PCR analysis of ocean pout total RNA from various tissues as 
seen on an agarose gel ................. . ... ...... ... .... ...... ..... .................. .. 35 
7. Sequence consensus between the OP5a gene sequence between 
primers OPRT -F and OPRT -R and those obtained from sequencing of 
RT-PCR products from ocean pout blood, brain and liver ...................... 37 
8. Northern blot analysis of t-OP5a transgenic Atlantic salmon total 
RNA from various tissues as seen on a formaldehyde agarose gel. ....... .40 
9. RT-PCR analysis of t-OP5a transgenic Atlantic salmon total RNA 
from various tissues as seen on an agarose gel. ................................ 41 
10. Sequence consensus between the OP5a gene sequence between 
primers OPRT-F and OPRT-R and those obtained from sequencing of 
PCR products from t-OP5a transgenic Atlantic salmon brain .............. .. .43 
11. Northern blot analysis of E0-1a transgenic Atlantic salmon total 
RNA from various tissues as seen on a formaldehyde agarose gel. ....... .45 
12. RT-PCR analysis of E0-1a transgenic Atlantic salmon total RNA 
from various tissues as seen on an agarose gel (GH specific) ............... 46 
13. RT -PCR analysis of E0-1 a transgenic Atlantic salmon total RNA 
from various tissues as seen on an agarose gel (Actin control) ... ...... .. .. .48 
viii 
14. Sequence consensus between the opAFP-GHc2 gene construct 
sequence between primers A-F and D-R and those obtained from 
sequencing of PCR products from E0-1a transgenic Atlantic salmon 
muscle and spleen ............................................. ... .. ...... ... . .. .... .... .49 
15. Ice crystal from ocean pout blood plasma illustrating bipyrimidal 
shaping due to the presence of a high concentration of AFP .......... .. ..... 51 
16. Ice crystal from t-OP5a transgenic Atlantic salmon BS 3009 blood 
plasma illustrating hexagonal shaping due to the presence of a low 
concentration of AFP ................................... ... ... . .. . .. ....... ... .. . .. . .... 52 
17. Ice crystal from E0-1a transgenic Atlantic salmon 990456 blood 
plasma illustrating no shaping due to the absence of AFP ........ .. ...... .. .. 53 
ix 
1. Introduction 
1.1 General 
Teleost fish living in ice-laden sea water protect themselves from 
freezing by producing antifreeze proteins or glycoproteins (collectively termed 
AF(G)P). To date, five distinct classes of AF(G)P have now been 
characterized in fish termed antifreeze protein (AFP) type I, II , Ill, and IV and 
antifreeze glycoprotein (AFGP) (Fletcher eta/. 1999; Chan eta/. 1993; Ewart 
eta/. 1999; Marshall ef a/. 2004; Cheng, 1996). In summary, the type I AFP 
from righteye flounders (Pieuronectidae), shorthorn sculpins (Myoxocephalus 
scorpius) and snailfish (Liparus sp.) range in size from ca. 3.3 to 16,683 kDa, 
and are alanine rich amphipathic polypeptides with an a-helical secondary 
structure. Type II AFPs are found in sea raven (Hemitripterus americanus), 
smelts (Osmeridae) and herrings (Ciupeidae) , and are large (ca. 11-24 kDa), 
cystine rich molecules with a ~-sheet secondary structure. Type Ill AFPs from 
ocean pout (Macrozoarces americanus) and wolfish (Anarhichas lupus) are 
small (ca. 6.5 kDa) with a p-sandwich secondary structure and type IV from 
longhorn sculpin (Myoxocephalus octodecemspinosus) , are thought to be 
helix bundle proteins (ca. 12,296 kDa) . Finally, the antifreeze glycoproteins 
(AFGP) contain Ala-Ala-Thr repeats attached to a disaccharide and are found 
in Antarctic nototheniods and Northern cods (Gadus morhua, G. ogac). 
Despite the wide variety of fish species that produce AF(G)P, and that 
they are all biochemically distinct, they all function by lowering the 
freezing point of aqueous solutions non-colligatively, while having virtually no 
effect on their melting point (Fletcher eta/. 1992). This results in a 
temperature gap between the freezing and melting temperatures, known as 
thermal hysteresis, which is now used as a measure of antifreeze protein 
activity. 
The mechanism of action involves binding to seed ice crystals thereby 
inhibiting their growth by preventing water from joining the ice lattice (Fletcher 
eta/. 1992; Fletcher eta/. 1999). As a result of this specific binding, these 
molecules are up to 500 times more effective at lowering the freezing 
temperature than any known solute molecule (Fletcher eta/. 1999). 
Most of the AF(G)P producing teleost fish inhabiting the potentially ice-
laden waters off the northeastern coast of North America have distinct 
seasonal cycles in the expression levels of AF(G)P in the blood plasma that 
are inversely correlated with sea water temperatures. For example, winter 
flounder, shorthorn sculpin and Atlantic cod (Fletcher eta/. 1985) produce 
negligible levels of AF(G)P during the summer and high levels during the 
winter. One exception to this generalization is the ocean pout where plasma 
AF(G)P levels remain relatively high during the summer, suggesting that 
AF(G)P genes in this species are expressed constitutively. 
Other exceptions to the cyclic pattern of AF(G)P production can be 
found in species of fish that live in polar waters where the temperatures are 
near freezing year-round. For example, the Arctic sculpin (Myoxocephalus 
scorpius) and some Antarctic nototheniods (Trematomus borchgrevinki and 
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Rhigophilia dearborm) may be genetically predisposed to produce AF(G)P 
year round in response to the constant environmental threat of freezing 
(DeVries and Lin , 1977; Fletcher eta/. 1982). 
Research on the annual cycle of AF(G)P gene expression has 
concentrated on the winter flounder. There are three elements involved in 
AF(G)P gene expression at the level of transcription: tissue specificity, 
environmental cues and endocrine control (Davies eta/. 1999). The liver was 
found to be the source of the plasma AF(G)P, and eDNA cloning has showed 
that the abundant preproproteins forms are encoded in the liver mRNA 
(Pickett eta/. 1984). With the use of mRNA probes it was clearly 
demonstrated that the annual cycle of AF(G)P mRNA levels in the liver was 
closely associated with the annual cycle of plasma AF(G)P levels (Pickett et 
a/. 1984). 
The primary environmental factor involved in regulating the annual 
cycle of AF(G)P expression in winter flounder liver is photoperiod which, 
acting through the central nervous system, controls the production and 
secretion of growth hormone (GH) by the pituitary gland (Fletcher eta/. 1989). 
The current hypothesis is that growth hormone inhibits the production of 
AF(G)P during the summer when the fish are feeding, and during the fall, 
shortening day lengths result in the decline of plasma GH levels below that 
needed to suppress AF(G)P mRNA transcription (Idler eta/. 1989; Miao eta/. 
2002; Vaisius eta/. 1989). Details of the proposed mechanism for GH 
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suppression of AF(G)P gene transcription in the winter flounder liver has been 
presented by Chan eta/. (1997), Miao eta/. (1998a) and Miao eta/. (2002). 
Until quite recently, the generally accepted idea was that AF(G)P were 
expressed and synthesized solely in the liver from where they are secreted 
into the blood for circulation throughout the body, providing extra-cellular 
freeze protection to the fish by lowering the freezing point of the body fluids to 
that of the surrounding sea water. This view changed, however, when Gong 
eta/. (1992) discovered AF(G)P gene expression in a wide variety of tissues 
in the winter flounder and ocean pout; type I AFP and type Ill AFP producers, 
respectively. This study suggested that these AF(G)P genes had little or no 
tissue specificity. However, in a follow-up experiment, Gong eta/. (1995) 
noted that the DNA sequences obtained from eDNA clones isolated from the 
skin of winter flounder were more similar to each other then to the clones 
isolated from the liver. Finally, upon detailed examination of a skin eDNA 
library from the winter flounder, they discovered that there were actually two 
distinct families of AFP genes responsible for the expression pattern 
previously observed. These were named "liver-type", for those expressed 
solely in the liver and secreted into the blood, and "skin-type" for those 
expressed in a variety of tissues, but mainly in external epithelia (Gong eta/. 
1995). 
An interesting characteristic of these "skin-type" AFP is the absence of 
a signal sequence and a pro-region . The absence of a signal sequence 
suggested that the skin-type AFP remained intracellular. This was supported 
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by the fact that no skin-type AFP had been found in the blood plasma of 
winter flounder (Gong eta/. 1995). However, recent immunohistochemical 
studies of winter flounder tissues suggest that this may not always be the 
case. In these studies, Murray eta/. (2002, 2003) found that the skin-type 
AFP was indeed restricted to the cytoplasm of gill epithelial cells. However, in 
the skin these AFP could only be found located outside of the cells in the 
interstitial space. This signifies that despite the lack of a signal sequence 
skin-type AFP can be exported from the cells . 
Since their discovery in winter flounder, other "skin-type" AFP have 
been discovered and characterized in the shorthorn sculpin (Myoxocephalus 
scorpius) (Low eta/. 1988), longhorn sculpin (Myoxocepha/us 
octodecemspinosus) (Low eta/. 2001 ), and in the Atlantic and dusky snailfish 
(Liparus at/anticus and L. gibbus, respectively) (Evans and Fletcher, 2001) 
illustrating that the presence of "skin-type" AFP in external epithelia is a 
widespread biological phenomenon. It is hypothesized that these AFP prevent 
the propagation of ice crystals into and across the epidermis itself, thereby 
providing a first line of defense against ice formation and thus cell damage. 
1.2 Ocean Pout 
The ocean pout produces a family of at least 12 independently active 
AFP, which lack pro-sequences and are fully functional post-translationally 
(Li eta/. 1985; Hew eta/. 1988). In Newfoundland populations, these AFP 
occur at concentrations of 20-25 mg/ml in the blood plasma during the winter 
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and are maintained at approximately half of this level during the summer. In 
contrast, plasma AFP concentrations in New Brunswick populations of ocean 
pout are only a tenth of those found in Newfoundland (Fletcher eta/. 1985). 
Genomic Southern analyses revealed that there are approximately 1 00-150 
copies of the AFP genes in Newfoundland ocean pout whereas there are less 
than a quarter as many AFP genes in the New Brunswick ocean pout (Hew et 
a/. 1988). This strongly suggests that the level of expression of AFP in ocean 
pout is dependent on gene copy number. 
A study of antifreeze protein gene expression in ocean pout using 
northern blot analysis revealed that AFP was produced in most tissues, with 
the highest levels occurring in the liver (Gong eta/. 1992). Given that there 
are 1 00-150 AFP genes in the ocean pout, it is unlikely that the eDNA probe 
[(corresponding to AFP SP1-C (HPLC-6) (Li eta/. 1985, Hew eta/. 1988)] 
used to detect the AFP mRNA was specific to any particular AFP gene. 
Therefore, it is unknown as to whether the ocean pout, like the winter 
flounder, possess AFP gene families which differ with regards to tissue 
specific expression. 
Over the past 1 0-15 years , one of the ocean pout AFP genes (OP5a) 
(Figure 1) has been used with the goal of assisting the aquaculture industry 
by producing genetically superior transgenic Atlantic salmon brood stocks that 
are capable of being cultured in sea cages throughout Atlantic Canada. 
One problem faced by the aquaculture industry in eastern Canada is 
the widespread prevalence of sub-zero water temperatures and ice during the 
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1 2115 2182 2726 
1612 1449 
• • 506 bp 
OPRT-F OPRT-R 
·---~·-184/366 bp 
- Ocean Pout AFP 5' promoter region 
Ocean Pout AFP 3' region 
- Ocean Pout AFP coding sequence Exon 
- Ocean Pout AFP Intron 
Ocean Pout 5' untranslated region 
Figure 1: Structure of the ocean pout type Ill AFP gene (Op5a). 
PCR primers used in transgenic identification are indicated. An 
intron between primers OPRT -F and OPRT -R results in a 184 
bp product in eDNA and a 366 bp product in genomic DNA. 
Figure modified from Wu (1994). 
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winter. The cold water conditions result in slow growth rates and , when 
combined with the presence of ice, they can be lethal. Therefore, sea cage 
culture of salmon is almost entirely restricted to a relatively small area in the 
most southerly part of the Atlantic region. The aim of the transgenic research 
was to produce salmon with enhanced growth rates and improved freeze 
resistance. A successful outcome from one or both of these tasks could help 
facilitate the expansion of aquaculture and thus economic development 
throughout the entire Atlantic coastal region (Hew eta/. 1999; Hew et a/. 
1995; Du eta/. 1992a; Fletcher eta/. 2001 ). 
Two lines of transgenic salmon have been produced utilizing an ocean 
pout antifreeze gene; one that was created from the transfer of a truncated 
version of the OP5a AFP gene (t-OP5a) (Wu 1994), and the other from the 
transfer of a chimeric growth hormone (GH) gene consisting of the promoter 
region from the OP5a AFP gene linked to a Chinook salmon GH eDNA 
(opAFP-GHc2) (Du eta/. 1992a, 1992b). 
Since the elements of a gene that direct tissue specific expression 
generally lie within the promoter region (von Hippel eta/. 1982; de Freitas et 
a/. 1994; Dynan and Tjian , 1985) the two transgenic salmon lines serve as 
excellent models that can be used to determine the tissue specificity of the 
ocean pout OP5a AFP gene promoter. 
The objective of this study is to determine the tissue specific 
expression of the t-OP5a and E0-1 a transgenes in transgenic Atlantic salmon 
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using RT-PCR and northern blotting procedures, and compare these 
expression patterns to that of the OP5a AFP gene in ocean pout. 
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2. Materials and Methods 
2.1. Experimental Animals 
Ocean pout (Macrozoarces americanus) were caught by SCUBA 
divers in Conception Bay, Newfoundland and Labrador, transported live to the 
Ocean Sciences Centre and maintained in 300 liter aquaria at seasonally 
ambient conditions of temperature and photoperiod. 
Atlantic salmon were obtained from Newfoundland stocks cultured at 
the Ocean Sciences Centre. Three distinct strains were used in this study: 
one strain transgenic for an ocean pout antifreeze protein gene (t-OP5a) , a 
second strain transgenic for a Chinook salmon growth hormone gene (E0-1a) 
and a third non-transgenic control strain (for details see Table 1 ). All salmon 
were fed a commercial salmon feed (Corey Feeds) to satiation once daily. 
The transgenic strain (t-OP5a) of Atlantic salmon containing an ocean 
pout antifreeze protein gene (OP5a) was created in 1990 by injecting fertilized 
Atlantic salmon eggs with a truncated OP5a genomic clone (t-OP5a) (Figure 
2) (Wu 1994). The specific salmon used in this study were F2 offspring 
resulting from a cross between an F1 generation male and a control (wild 
type) female. Approximately 50% of these F2 offspring inherited the OP5a 
transgene, indicating that the transgene was integrated into a single 
chromosome. Salmon were identified as transgenic via polymerase chain 
reaction (PCR) prior to this study as previously described (Wu 1994). 
The transgenic strain (E0-1 a) of Atlantic salmon containing the 
Chinook salmon growth hormone gene was created in 1989 by injecting 
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Table 1. Characteristics of transgenic fish used in RT-PCR and Northern 
analyses. 
Fish Name Fish Line/Cross Fish # Weight (g) c Age (yrs.) Experiment 
t-OP5a 1 ASC 4565 x Wild BS 3009 1000 6 RT-PCRa 
t-OP5a 2 ASC 4565 x Wild BS 3033 1000 6 RT-PCRa 
t-OP5a 3 ASC 4565 x Wild BS 3073 1000 7 Northem0 
t-OP5a 4 ASC 4565 x Wild BS 3111 1000 7 Northem0 
E0-1a 1 960048 X Wild 990456 400 2 RT-PCRa 
EO-la 2 960044 X Wild 990371 400 2 RT-PCRa 
E0-1a 3 960044 X Wild 990247 800 ., Northemb .) 
EO-la 4 960044 X Wild 990233 800 3 Northemb 
a Used for reverse transcription polymerase chain reaction experiments. 
b Used for Northern blot analyses. 
c Denotes approximate weight at time of death. 
fertilized Atlantic salmon eggs with a chimeric gene construct consisting of the 
OP5a antifreeze protein gene promoter linked to a Chinook salmon growth 
hormone eDNA (opAFP-GHc2) (Figure 3) (Duet a/. 1992a, 1992b). This 
construct has been fully characterized in the transgenic salmon revealing 
rearrangements resulting in truncation of the promoter region (Figure 4). The 
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184/366 bp 
Ocean Pout AFP 5' promoter region 
Ocean Pout AFP 3' region 
Ocean Pout AFP coding sequence Exon 
Ocean Pout AFP Intron 
Ocean Pout AFP 5' untranslated region 
Figure 2: Structure of the truncated ocean pout AFP gene injected 
into Atlantic salmon eggs to produce t-OpSa transgenic Atlantic 
salmon. PCR primers used in transgenic identification are indicated. 
An intron between primers OPRT-F and OPRT-R results in a 184 bp 
product in eDNA and a 366 bp product in genomic DNA. Figure 
modified from Wu (1994). 
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1 2115 2187 2897 
2653 2654 
1---1 
207bp 
A-F D-R 
I I 
331 bp 
- Ocean Pout AFP 5' promoter region 
Ocean Pout AFP 3' region 
Salmon GH eDNA 
- Ocean Pout AFP 5' untranslated region 
Figure 3: Structure of the "all fish chimeric gene construct" (opAFP-
GHc2) injected into Atlantic salmon eggs to produce E0-1 a 
transgenic Atlantic salmon. PCR and RT -PCR primers used as well 
as predicted band sizes are indicated. Figure modified from Du et a/. 
1992a. 
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1580 2115 2187 2897 4061 1 
2653 2654 
1--1 
207bp 
A-F D-R 
I I 
331 bp 
- Ocean Pout AFP 5' promoter region 
Ocean Pout AFP 3' region 
Salmon GH eDNA 
- Ocean Pout AFP 5' untranslated region 
pUC vector 
Figure 4. Schematic of the proposed structure of the E0-1a 
construct in transgenic Atlantic salmon. PCR primers used as well 
as predicted band sizes are indicated. Personal Communication, 
Ed Yaskowiak, AQUA Bounty Technologies, St. John's, 
Newfoundland and Labrador, Canada. 
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resulting transgene (E0-1 a) and its rapid growth phenotype have exhibited 
stable Mendelian inheritance over 5 generations to date (unpublished data). 
The salmon used in the present study are from the F 4 generation. 
Approximately 50% of these F 4 offspring inherited the E0-1 a gene construct, 
indicating that the transgene was integrated into a single chromosome. P1 
and F1 salmon were identified as transgenic prior to this study as previously 
described (Du eta/. 1992a, 1992b). Subsequent generations were identified 
using primers 2653/2654 as indicated in Figures 3 and 4. Three of the fish 
lines used in the present study (ocean pout, t-OP5a transgenic salmon and 
E0-1a transgenic salmon) contain the intact 3' region of the OP5a AFP gene. 
2.2. Tissue sampling 
Fish were anesthetized (3-aminobenzoic acid ethyl ester, 2 g/L, two 
minutes), blood sampled from a caudal blood vessel using a 5 cc syringe with 
a 21 gauge needle and then killed by anesthetic overdose (3-aminobenzoic 
acid ethyl ester, 2 g/L, 10 minutes). Tissues samples (stomach, intestine, 
spleen, liver, full kidney, heart, brain, pituitary, gonad, skin, gills, mouth skin, 
and muscle) were removed from the fish as rapidly as possible and immersed 
in RNA/ater™ RNA stabilization solution (Qiagen Inc., Chatsworth , CA) for 24 
hours followed by storage at -70°C. Whole blood samples were divided into 
two portions, one portion was immediately frozen in liquid nitrogen and stored 
at -70 °C, and the other portion was centrifuged at 5000 x g for 15 minutes 
and the plasma stored at -70 °C until analyzed. 
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2.3. RNA Isolation 
Total RNA was isolated using a commercially available RNA isolation 
method. (TRizol® reagent; Invitrogen Life Technologies, Burlington, ON) 
(Chomczynski and Sacchi , 1987). Approximately 50 - 100 mg of tissue was 
homogenized in one ml of Trizol using disposable 1.5 ml pestles and tubes 
(Kontes glass company, Vineland, NJ). Samples were then centrifuged at 
12,000 x g for 10 minutes at 6°C after which the clear homogenate was 
transferred to a fresh microcentrifuge tube. Samples were incubated at room 
temperature for five minutes and 0.2 ml chloroform was added. The samples 
were then shaken vigorously by hand for 15 seconds and incubated at room 
temperature for three minutes followed by centrifugation at 12,000 x g at 6°C 
for 15 minutes. This separated the sample into three phases, the lower 
phenol-chloroform phase, an interphase, and a clear upper phase. The upper 
aqueous RNA containing phase was transferred into a fresh microcentrifuge 
tube and 0.5 ml isopropyl alcohol was added. The samples were then 
incubated at room temperature for 10 minutes followed by centrifugation at 
12,000 x gat 6°C for 10 minutes. The RNA pellet was washed once with one 
ml of 75% ethanol and centrifuged at 7,500 x g at 6°C for 5 minutes. The RNA 
pellet was then briefly air-dried and resuspended in Dnase/Rnase free water 
(lnvitrogenr", Burlington, ON). Finally, the concentration was determined using 
the GeneQuant pro RNA/DNA Calculator (Amersham Pharmacia Biotech, 
Cambridge, ON). 
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2.4. Probe Production 
2.4.1. Bacterial Preparation 
E. coli bacteria (genotype: F-mcrA ~(mrr-hsdRMS-mcrBC) 
<D80/acZ~M15 ~lacX74 recA1 deaR araD139 ~(ara-leu)7697 ga/U ga/K rpsl 
(StrR) endA 1 nupG) were grown in Luria-Bertani (LB) medium (1 0 g/L bacto-
tryptone; five g/L bacto-yeast extract; 10 g/L NaCI, pH 7.0) which was 
supplemented with ampicillin (1 00 1-1g/ml) based on the resistance gene 
encoded by the plasmid used (pCR®II-TOPO®: Invitrogen Life Technologies 
Burlington, ON). The cultures were grown overnight with vigorous shaking at 
37°C. 
Transformations were carried out according to TOPO TA Cloning® 
(Invitrogen Life Technologies, Burlington, ON). Essentially, a cloning solution 
was mixed containing four 1-11 of fresh PCR product of the gene sequence of 
interest (see following paragraph), one 1-11 salt solution (1.2 M NaCI; 60 mM 
MgCb) and one 1-11 pCR® II TOPO® vector and incubated at room temperature 
for 30 minutes. Next, two 1-11 of this solution was added to a vial of chemically 
competent E. coli, mixed and incubated on ice for 30 minutes. The cells were 
then heat shocked for 30 seconds at 42°C and held on ice. 250 1-11 of room 
temperature SOC medium (2% Tryptone; 0.5% yeast extract; 10 mM NaCI; 
2.5 mM KCI; 10 mM MgCI2 ; 10 mM MgS04 ; 20 mM glucose) was added to the 
solution and shaken horizontally (200 rpm) at 37°C for 1 hour. Approximately 
50 1-11 of this solution was then added to pre-warmed, X-gal in 
dimethylformamide (DMF) treated (40 1-11 of 40 mg/ml solution/ plate) LB agar 
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(1 0 g/L bacto-tryptone; five g/L bacto-yeast extract; 10 g/L NaCI, pH 7.0; 15 
g/L bacto-agar) plates supplemented with ampicillin (1 00 J.lg/ml) and 
incubated over night at 37°C. Individual colonies were then patch-plated for 
short-term maintenance. Bacteria were stored by picking cells from an 
individual colony or cells from a patch-plate and streaked on a fresh LB agar 
plate supplemented with ampicilin (1 00 J.lg/ml) periodically. 
The gene sequence of interest for ocean pout and t-OP5a transgenic 
Atlantic salmon was obtained from RT-PCR using primer set OPRT-F/OPRT-
R. The gene sequence of interest for E0-1 a transgenic Atlantic salmon was 
obtained from RT-PCR using primer set A-F/0-R. The internal control ( ~­
actin) gene sequence of interest was obtained from RT-PCR using primer set 
Actin-F/Actin-R (see Section 2.7). 
2.4.2. Small-Scale Plasmid Purification 
Small-scale plasmid purification was performed using a commercially 
available affinity resin in conjunction with a modified alkaline lysis protocol 
(Qiagen Inc., Chatsworth, CA) (Birnboim and Daly, 1979). A single colony 
was inoculated into two ml of LB media supplemented with ampicillin (1 00 
J.lg/ml) and incubated with shaking overnight at 37°C. A 1.5 ml aliquot of the 
culture was transferred to a 1.5 ml microfuge tube and the cells were pelleted 
by centrifugation in a tabletop microfuge at 10,000 x g for 30 seconds. The 
supernatant was aspirated and the bacterial cell pellet was resuspended in 
200 J.ll of P1 Resuspension Buffer (50 mM Tris-CI, pH 8.0; 10 mM EDTA; 100 
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f.lg/ml RNase A) by vortexing. The cells were lysed by the addition of 200 f..!l 
of P2 Lysis Buffer [200 mM NaOH; 1% SDS (w/v)] and inverting the tubes six 
times to mix. The solution was then neutralized by the addition of 200 f.ll of N3 
Neutralization Buffer (Proprietary composition; Qiagen Inc., Chatsworth, CA) 
and mixing the tubes immediately by inverting six times. Next, the samples 
were centrifuged at 10,000 x g for 10 minutes, after which the supernatant 
was removed and applied to a QIAprep Spin Column (Qiagen Inc., 
Chatsworth, CA) according to the manufacturer's protocol. The plasmid DNA 
was then eluted in 50 f.ll of 10 mM Tris-HCI (pH 8.5). The resulting DNA was 
analyzed using a diagnostic restriction enzyme (RE) digest as well as direct 
sequencing (See section 2.10 for details). For a diagnostic digest, four f.ll of 
the resulting DNA was digested with one f.ll EcoRI for 1 1/2 hours at 37°C, 
and the resulting DNA fragments analyzed by agarose gel electrophoresis. 
2.4.3. Large-Scale Plasmid Purification 
Large-scale plasmid purification was performed using a commercially 
available anion-exchange resin in conjunction with a modified alkaline lysis 
protocol (Qiagen Inc., Chatsworth, CA)(Birnboim and Daly, 1979). A single 
colony was inoculated into 150 ml of autoclave sterilized LB media 
supplemented with ampicillin (1 00 f.lg/ml) and incubated with shaking 
overnight at 37°C. The solution was poured into plastic centrifuge tubes and 
centrifuged at 6,300 rpm for 15 minutes at 4°C. The supernatant was 
discarded into bleach. Next, the pellet was resuspended in 10 ml of P1 
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Resuspension Buffer by vortexing and pipetting up and down using a 1 0 ml 
disposable pipette. The cells were then lysed by adding 10 ml of P2 Lysis 
Buffer, mixed by inverting the tubes six times and incubating at room 
temperature for five minutes. Next, 10 ml of chilled P3 Neutralization Buffer 
(3.0 M potassium acetate, pH 5.5) was added , immediately mixed by inverting 
the tubes six times and incubated on ice for 15 minutes. The tubes were then 
centrifuged at 13,300 rpm for 30 minutes at 4°C, after which the supernatant 
was filtered through cheesecloth. This solution was run through a Qiagen-tip 
100 Anion-Exchange Resin (Qiagen Inc., Chatsworth, CA) according to the 
manufacturer's protocol to purify the plasmid DNA. The Qiagen-tip was then 
washed with two x 30 ml of QC Wash Buffer [1.0 M NaCI; 50 mM MOPS, pH 
7.0; 15% isopropanol (v/v)], and the DNA eluted in 15 ml of QF Elution Buffer 
[1 .25 M NaCI; 50 mM Tris-CI, pH 8.5; 15% isopropanol (v/v)]. Next, The DNA 
was precipitated by adding 10.5 ml of room temperature isopropanol to the 
eluted DNA, mixing and centrifuging at 5,000 x g for one hour at 4°C. After 
decanting the supernatant, the DNA pellet was washed with room 
temperature 70% ethanol followed by centrifugation at 5000 x g for one hour 
at 4°C. Finally, the pellet was air-dried until the ethanol completely 
evaporated (approximately 30 minutes) and then redissolved in 250 I--ll TE 
buffer (1 0 mM Tris-CI, pH 8.0; 1 mM EDTA). The concentration of the purified 
plasmid DNA was measured using the GeneQuant pro RNA/DNA Calculator 
(Amersham Pharmacia Biotech, Cambridge, ON). The plasmid was then 
linearized at a restriction site downstream of the cloned insert according to 
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standard RE protocol (Invitrogen Life Technologies, Burlington, ON). 
Specifically, 1 0 ).!g of plasmid DNA was cut using 1 0 ).!1 of the appropriate RE 
and 1 0 ).!1 of the appropriate RE buffer by incubating at 37°C for 1 % hours. 
The linearized plasmid was then purified using the QIAquick Gel Extraction 
Kit (Qiagen Inc., Chatsworth , CA) as per manufacturer's protocol. Essentially, 
the DNA sample was separated on a 1.5% agarose gel after which the DNA 
was excised and the agarose dissolved by incubating in three gel volumes of 
QG Buffer at 50°C. Next, one gel volume of isopropanol was added and the 
sample was pipetted into a QIAquick spin column. The sample was 
centrifuged at 13,300 x g for one minute and the flow through discarded. The 
DNA was washed by adding 0.75 ml of Buffer PE to the column and spinning 
at 13,300 x g for one minute. The flow through was discarded, and the 
column was spun again at 13,300 x g for one minute. Finally, the column was 
placed in a clean microcentrifuge tube, and the DNA was eluted by adding 50 
).!I of water to the center of the column and spinning at 13,300 x g for one 
minute. The concentration of the purified linearized plasmid DNA was 
measured using the GeneQuant pro RNA/DNA Calculator (Amersham 
Pharmacia Biotech, Cambridge, ON). 
2.4.4. DIG-RNA Labelling 
RNA was labelled for use as a probe for northern blot analyses in an in 
vitro transcription reaction with digoxigenin-11-UTP (DIG) according to 
manufacturers protocol (DIG Northern Starter Kit, Roche Applied Science, 
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Laval , QC). Specifically, one J.lg of linearized plasmid containing the gene 
sequence of interest in a total volume of 10 J..tl was added to four J..tl of 5 x 
Labelling mix, four J..tl of 5 x Transcriptional buffer and two J.ll of RNA 
polymerase (either SP6 or T7 depending on the orientation of the insert in the 
plasmid) on ice. The solution was then mixed and centrifuged briefly, followed 
by incubation at 42°C for one hour. Any remaining DNA template was then 
removed by adding two J..tl DNase I and incubating at 37°C for 15 minutes. 
Finally, the reaction was terminated by adding two J..tl of 0.2 M EDTA (pH 8.0). 
2.5. Northern blot analysis 
Formaldehyde agarose gel electrophoresis was performed as per 
methods outlined in DIG Northern Starter Kit (Roche Applied Science, Laval, 
QC) with modifications. A 1.2% formaldehyde agarose gel was prepared with 
1 x MOPS buffer (20 mM MOPS; 5 mM NaAc; 1 mM EDTA; pH 7.0) and 0.22 
M formaldehyde by adding 0.96 g agarose (Invitrogen Life Technologies, 
Burlington, ON) to 78.6 ml 1 x MOPS buffer and boiling in a microwave oven 
until the agarose had completely melted. After cooling to approximately 50 °C, 
1.5 ml of a 37% formaldehyde solution (Fisher Scientific, Nepean, ON) was 
added and the solution was poured into a gel tray containing a gel comb and 
allowed to set. For ocean pout samples, two J.lg total RNA was used for each 
tissue, while 1 0 J.lg total RNA was used for t-OP5a transgenic salmon and 40 
J.lg total RNA was used for E0-1a transgenic salmon. Samples were 
prepared in a final volume of 5-10 J..tl with water. 15-30 J..tl of freshly prepared 
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loading buffer (250 )-ll of 100% formam ide; 83 )-ll of 37% formaldehyde 
solution; 50 )-ll 10 x MOPS; 50 )-ll 100% Rnase free glycerol; 10 )-ll 2.5% 
bromophenol blue; 57 )-ll water; six )-ll of 1.0 mg/ml ethidium bromide) (3:1 
ratio with RNA) was added to each sample, mixed and heated at 70°C for 10 
minutes and briefly chilled on ice. The addition of ethidium bromide enabled 
the RNA to be visualized directly without staining after electrophoresis. The 
samples were applied to the lanes of the gel and run at 130 V in 1 x MOPS 
until the bromophenol blue had run approximately 2/3 of the way down the 
gel. After electrophoresis the RNA was visualized via UV light and 
photographed using the Multilmage™ light cabinet and Alphalmager™ 1220 
Documentation and Analysis System (Alpha lnnotech Corporation, San 
Leandro, CA). 
RNA was transferred to a positively charged nylon membrane (Roche 
Applied Science, Laval, QC) using the VacuGene™ XL Vacuum blotting 
system (Amersham Biosciences, Piscataway, NJ) as per manufacturers 
protocol. Essentially, the membrane was wetted with 10 x SSC (1.5 M NaCI; 
150 mM sodium citrate, pH 7.0) and placed on a porous support screen which 
was pre-wetted with 2 x SSC. A plastic mask with a window cut slightly 
smaller than the membrane was then placed on the screen with the window 
over the membrane to create an airtight seal around the apparatus. The gel 
was positioned over the membrane avoiding air bubbles and the top frame 
was added and secured with clamps. The vacuum was then applied and set 
to approximately 50 mbar for two hours while ensuring that the gel was 
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constantly covered in 10 X sse. After the transfer period , the RNA was cross-
linked to the membrane twice via UV light using a UV Stratalinker® 2400 
(Stratagene®, La Jolla, CA) . Pre-hybridization and washing conditions were 
as per methods outlined in DIG Northern Starter Kit (Roche Applied Science, 
Laval, QC) with modifications. Initially, the membrane was soaked for one 
minute in Millipore (Millipore Corporation, Bedford, MA) filtered water, added 
to a hybridization tube containing 15 ml of DIG Easy Hyb solution (Roche 
Applied Science, Laval, QC) preheated to 68°C, and pre-hybridized with 
constant rotation for one-two hours in a hybridization oven/shaker (Amersham 
Biosciences, Piscataway, NJ). A DIG-labelled RNA probe was then denatured 
by boiling for five minutes followed by rapidly cooling on ice and was added to 
seven ml of DIG Easy Hyb solution preheated to 68°C. The pre-hybridization 
solution was poured out of the hybridization tube, and replaced with the 
probe-containing hybridization solution and hybridized with constant rotation 
overnight in a hybridization oven/shaker. After hybridization, the membrane 
was washed two x five minutes with stringency wash #1 (2 x SSC/ 0.1 % 
SDS) at room temperature, followed by two x 15 minute washing with 
stringency wash #2 (0.1 x SSC/ 0.1 % SDS) at 68°C. The remaining steps 
were performed at room temperature with gentle agitation unless otherwise 
instructed. The membrane was washed with 100 ml of Washing Buffer (DIG 
Wash and Block Buffer Set, Roche Applied Science, Laval , QC) by vigorous 
shaking for five minutes followed by incubation in Blocking Solution (DIG 
Wash and Block Buffer Set, Roche Applied Science, Laval, QC) for one hour. 
24 
This was followed by incubation in Antibody Solution (DIG Wash and Block 
Buffer Set, Roche Applied Science, Laval, QC) for 30 minutes. The 
membrane is then washed two x 15 minutes in Washing Buffer (DIG Wash 
and Block Buffer Set, Roche Applied Science, Laval, QC) with vigorous 
shaking followed by equilibration in Detection Buffer (1 M Tris-HCL (pH 9.5), 1 
M NaCI, DIG Wash and Block Buffer Set, Roche Applied Science, Laval, QC) 
for five minutes. The membrane was then placed inside a development folder, 
covered with COP-Star ready-to-use (Roche Applied Science, Laval, QC), 
and allowed to incubate for five minutes. Any excess fluid was then squeezed 
out and the folder sealed. Finally, the membrane was exposed to 
chemiluminescent film (Roche Applied Science, Laval, QC) for one- 60 
minutes. 
2.6. Reverse Transcription CRT) 
Prior to reverse transcription, all RNA samples were treated with 
amplification grade Deoxyribonuclease (DNase) I (Invitrogen Life 
Technologies, Burlington, ON). Basically, one )..lg of RNA along with one J..LI of 
1 0 x DNase I reaction buffer, one unit of DNase I, and water to 1 0 J..LI were 
added to a microcentrifuge tube and incubated at room temperature for 15 
minutes. The reaction was inactivated by adding one J..LI of 25 mM EDTA and 
heating at 65°C for 1 0 minutes. RT reactions were carried out using the 
Superscript"' II RNase H- Reverse Transcriptase kit (Invitrogen Life 
Technologies, Burlington, ON). In a 500 J..LI micro test tube, one )..lg of sample 
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RNA was added to one ~-tl of 10 ~-tM oligo-dT primer, one ~-tl of dNTP Mix 
[containing 10 mM of dATP, dGTP, dCTP, and dTTP (Invitrogen Life 
Technologies, Burlington, ON)] and water to a final volume of 12 1-l'- This was 
incubated at 65°C for five minutes and then held on ice. A cocktail containing 
four ~-tl of 5 x first strand buffer [250 mM Tris-HCL (pH 8.3) , 375 mM KCL, 15 
mM MgCb], two ~-tl 0.1 M OTT, and one ~-tl of RNaseOUTT ... recombinant 
ribonuclease inhibitor (Invitrogen Life Technologies, Burlington, ON) was then 
added and incubated at 42°C for two minutes, followed by addition of 200 
units of SuperscriptTM II reverse transcriptase. This was maintained at 42°C for 
50 minutes followed by inactivating the reaction by heating at 70 °C for 15 
minutes. Finally, the samples were treated with Ribonuclease H (Invitrogen 
Life Technologies, Burlington, ON). Essentially, two units of Ribonuclease H 
were added to the RT product and incubated at 37 °C for 20 minutes. 
2.7. Polymerase Chain Reaction (PCR) 
Table 2 lists the primer pairs used in the PCR reactions along with their 
annealing sites, while Figures 1 and 2 display the primer positioning with 
respect to the OP5a and t-OP5a gene constructs, and Figure 4 displays the 
primer positioning with respect to the E0-1 a gene construct. 
Primer set OPRT-F/OPRT-R was used to examine the tissue 
specificity of the OP5a gene in ocean pout (Figure 1). OPRT-F anneals to the 
OP5a coding sequence (cds) between bases 26- 46 while OPRT-R anneals 
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Table 2. Primer pairs used for polymerase chain reaction and their annealing 
sites. 
No. Name Seguencea Annealing siteb 
1. OPRT-F CGG TTT GCT TTT CGT CCT CCT OP5a CDS 
OPRT-R TGG CGT GTT CAC TTG CTT CC OP5a CDS 
2. 1612 GTC CTC CTT TGT GTC GAC CAC A TG A OP5a CDS 
1449 CCG GAC AGA CTT GGG TTT GTG ACA A OP5a 3' UTR 
3. A-F GTC AGA AGT CTC AGC TAC AGC OP5a promoter 
D-R ACA GAA GTC CAG CAG GAA TAT Salmon GH CDS 
4. 2653-F GCT CTT CAA CAT CGC GGT CA Salmon GH CDS 
2654-R ATA TGG AGC AGC TTC AGG AC Salmon GH CDS 
5. ACTIN-Fc CGCCGCACTGGTTGTTGACA Atl. salmon ~-actin 
ACTIN-Rc GCG GTG CCC ATC TCC TGC T Atl. salmon ~-actin 
a Primer sequences are written in the 5'~3' direction. The forward primer is 
listed first and the reverse primer second. Rand F denoted forward and 
reverse primers, respectively. 
b Indicates site of primer annealing on gene of interest. See Figures 1 and 2 
for the location of primer sets 1 and 2 and Figures 3 and 4 for the location of 
primer sets 3 and 4 relative to gene of interest. 
c Internal control used in PCR experiments. Amplify 675 bp portion of Atlantic 
salmon ~-actin gene. GenBank Accession# AF012125. 
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to the OP5a cds between bases 372 - 392 to yield a 184 base pair (bp) band 
in eDNA. 
In t-OP5a transgenic Atlantic salmon, two sets of primers were used to 
examine the tissue specificity of the OP5a gene (Figure 2) . The first set, 
1612/1449 was used to identify the fish used as transgenics 0/IJu 1994). The 
second set, OPRT-F/OPRT-R was used to examine the tissue specificity of 
the OP5a gene in transgenic Atlantic salmon as it was in ocean pout. 
In E0-1a transgenic Atlantic salmon, two sets of primers were used to 
examine the tissue specificity of the E0-1 a gene (Figure 4). The first set, 
2653/2654 was used to identify the fish used as transgenics (Du et a/. 
1992a). The second set, A-F/D-R was used to examine the tissue specificity 
of the E0-1a gene in transgenic Atlantic salmon. Primer A-F anneals to the 
OP5a 5' promoter region between bases 2080- 2100 while D-R anneals to 
the salmon GH cds between bases 198-218 to yield a 331 bp band. 
Finally, primer set Actin-F/Actin-R was used as an internal control to 
amplify a portion of the Atlantic salmon ~-actin gene. Actin-F anneals to the~­
actin cds between bases 15-34 while Actin-R anneals to the ~-actin cds 
between 671 - 689 to give a 675 bp band (not shown). 
The Atlantic salmon ~-actin gene primers were included in the PCR 
reaction mixture along with the OP5a AFP gene primers (OPRT-F/OPRT-R) 
to determine AFP gene expression in ocean pout and t-OP5a AFP transgenic 
salmon tissues. Separate reactions with ~-actin primers and E0-1 a 
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transgene primers (A-F /D-R) were carried out on the tissues of salmon 
transgenic for the E0-1 a transgene. 
Polymerase chain reactions were performed in a Mastercycler® 
gradient thermal cycler (Eppendorf Scientific, Westbury, NY) with 35 cycles of 
amplification. PCR amplification was achieved using Taq DNA polymerase 
(Invitrogen Life Technologies, Burlington, ON). Primers were designed using 
the Gene Tool Version 1.0 from Biotools.com and purchased from Cartee 
DNA Service Laboratories Inc. A 50 J.!l reaction contained two units Taq 
polymerase, 1 x PCR buffer (200 mM Tris-HCL (pH 8.4), 500 mM KCL), 1.5 
mM MgCb, four dNTP's [200 J.!M each of dATP, dGTP, dCTP, and dTTP 
(Invitrogen Life Technologies, Burlington, ON)], 100 ng template DNA, 0.2 ~-tM 
of both upstream and downstream primers and was held on ice. 
When all of the components were added to the reaction mixture, the 
samples were placed in the thermal cycler with the block preheated to 90 °C, 
and the lid preheated to 105 °C. The thermal cycling profile consisted of an 
initial denaturation at 94 °C for three minutes, followed by 35 cycles of 
denaturation at 94°C for 15 seconds, primer annealing at the appropriate 
temperature for 15 seconds and extension at 72 °C for 30 seconds. A final 
extension of four minutes at 72 °C was used to ensure complete extension. 
Samples were held at 4 °C until ready for agarose gel electrophoresis. 
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2.8. Agarose Gel Electrophoresis 
100 ml gels (1 .5- 2%) were prepared by combining 1.5- two g of 
agarose (Invitrogen Life Technologies, Burlington, ON) with 100 ml of 1 x TBE 
buffer (45 mM Tris-borate, 1 mM EDTA) and boiling in a microwave oven until 
the agarose was completely melted. The solution was allowed to cool to 
approximately 50 °C and poured into a gel tray containing a gel comb used for 
well formation and solidification of the gel. five J..LI of 6 x sample buffer (0.25% 
bromophenol blue; 0.25% xylene cyanol FF; 30% glycerol in water) was 
added to each sample and 12 J..LI per sample was added to the wells and 
electrophoresed in 1 x TBE running buffer at 100- 130 V until the sample 
buffer had migrated approximately 2/3 of the way down the gel. To estimate 
the size of the DNA fragments, a molecular weight standard (1 00 base pair 
ladder or 1 KB Plus DNA ladder; Invitrogen Life Technologies, Burlington, 
ON) was run along side the DNA samples. The DNA was visualized by 
staining with 0.5 1-lg/J..LI solution of ethidium bromide (Sigma®, Oakville, ON) for 
approximately 20 minutes followed by exposure to UV light and photographed 
using the Multilmage™ light cabinet and Alphalmager™ 1220 Documentation 
and Analysis System (Alpha lnnotech Corporation, San Leandro, CA). 
2.9. DNA Sequencing 
Samples were prepared via PCR and separated on agarose as 
previously described (sections 2.7 and 2.8). The band of interest was excised 
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and the DNA purified using the QIAquick® gel extraction kit (Qiagen Inc., 
Chatsworth, CA) and diluted with Dnase/Rnase free water (Invitrogen Life 
Technologies, Burlington, ON) to a final concentration of 10-20 ngl~-tl. DNA 
was sent to McMaster University's Mobix lab for sequencing to confirm 
sequence identity of products obtained from PCR. The ABI Big Dye 
terminator cycle sequencing chemistry was used to perform DNA sequencing. 
Conditions for the standard sequencing reaction were: annealing temperature 
50°C, extension 60°C, 2.5 mM MgCb and primer concentration is 0.2 mM. 
After the completion of the sequencing reaction, excess primer and 
unincorporated ddNTP's were removed using DyeEx columns (Qiagen Inc. , 
Chatsworth, CA) and the DNA precipitated using sodium acetate and 
ethanol. The purified reaction was then resuspended in HiDi formamide (ABI) 
and the sample is placed in the 3100 DNA automated sequencer. Results 
were provided as alphabetic sequences as well as chromatograms. The 
chromatograms were proof read to confirm the alphabetic sequences. 
2.1 0. Thermal Hysteresis Measurements 
Thermal hysteresis, the difference between the freezing point and 
melting point of a solution, was used as a measure of antifreeze activity in 
plasma samples from all fish used in the study. The method used was based 
upon the methods used in Kao eta/. (1986). Plasma samples were placed in 
cylindrical wells on a metal plate, which was placed on a cooling stage and 
viewed through a compound microscope. The microscope was connected to 
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a monitor to allow for straightforward viewing of samples. For each individual 
sample, triplicate measurements of the freezing and melting points of a single 
ice crystal were obtained using a Clifton nanoliter osmometer (Clifton 
Technical Physics, Hartford, NY)(1 000 mOsmols = -1 .86°C) and the average 
was used to calculate the thermal hysteresis of the sample. Control 
measurements were obtained by measuring the freezing and melting points of 
deionized water, and used to correct for background error of the osmometer. 
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3. Results 
3.1. Expression of the OP5a AFP gene in ocean pout. 
The relative level of expression of the ocean pout OP5a AFP gene was 
examined by northern analysis in ocean pout tissues obtained from two 
individuals. A blot obtained from a single individual is shown in figure 5. The 
results for these two individuals were identical, with AFP mRNA being 
detected in most tissues. The levels of AFP mRNA in the tissues could be 
ranked as follows: Liver> stomach and gill > skin, mouth skin, intestine, 
spleen, and kidney> ovary, heart> brain, and blood cells. No AFP mRNA 
was detected in muscle tissue, however see RT-PCR analysis below. These 
results are similar to those obtained by Gong eta/. (1992). The control 13-actin 
mRNA was readily detectable in all tissues with the exception of the liver 
where the band was barely detectable. This low level of 13-actin mRNA in liver 
is likely due to the excess of AFP mRNA relative to the 13-actin mRNA present 
in the two micrograms of total RNA loaded onto the gel (Figure 5). Although 
13-actin mRNA was detected in muscle, hybridization was visualized at a lower 
position on the gel with respect to all other tissues. 
RT-PCR analysis indicated the presence of OP5a AFP and 13-actin 
mRNA in all tissues including muscle as evidenced by the 184 bp and 675 bp 
bands, respectively (Figure 6). Both of the negative control (non-transgenic) 
Atlantic salmon testes were positive for the 13-actin mRNA and negative for 
the AFP mRNA. An extra, higher molecular weight band (approximately 750 
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Figure 5. Northern blot analysis of ocean pout total RNA from various 
tissues as seen on a formaldehyde agarose gel. 2 J.lg total RNA was 
added for each sample. Top panel probed for ocean pout OP5a AFP RNA. 
Middle panel probed for Atlantic salmon ~-actin RNA. Bottom panel is RNA 
after electrophoresis viewed under ultra violet light. Lane 1 is the DIG-
labeled RNA Marker I from Roche Applied Science in bases (60 ng used). 
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Figure 6. RT-PCR analysis of ocean pout total RNA from various 
tissues as seen on an agarose gel. Primers were designed from the 
Atlantic salmon !3-actin gene sequence and the ocean pout Op5a 
antifreeze protein gene sequence to give a 675 base pair (bp) product 
and a 184 bp product, respectively. Wild Atlantic salmon testes RNA 
was used as a negative control for the Op5a antifreeze protein gene. 
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bp) was also observed in muscle when tested for ~-actin. Similarly, intestine 
yielded a higher molecular weight band (approximately 220 bp) when tested 
for AFP. The absence of a 366 bp band that could have been generated by 
the primer set OPRT-F/OPRT-R if genomic DNA was present indicates that 
the RNA was not contaminated by genomic DNA (see Figure 2). 
Sequence analysis of the AFP bands from brain and blood cells that 
had been amplified by RT-PCR indicated that they were indeed derived from 
a type Ill AFP gene (Figure 7). However, there are three possible base pair 
changes from the OP5a sequence in brain and blood samples located at 
bases 79, 99 and 145 (Figure 7) due to multiple peaks present on the 
sequencing chromatogram (data not shown). Also, sequencing of three liver 
samples from ocean pout identified combinations of these three base pair 
changes. In the Liver 1 sample, the base at location 79 is guanine in contrast 
to the adenine in the OP5a sequence while base 99 is cytosine in contrast to 
thymine in OP5a, corresponding to HPLC 9 in Hew eta/. (1988). In addition, 
there is a base change from cytosine to thymine at position 46 (Figure 7). In 
the Liver 2 sample, once again, the base at location 79 is guanine in contrast 
to adenine in OP5a, while at position 99, the base matches that of OP5a, 
corresponding to HPLC 1 in Hew eta/. (1988). Finally, in the Liver 3 sample, 
the base at position 79 matches that of the OP5a sequence while at position 
99 is cytosine in contrast to thymine in OP5a, corresponding to HPLC 4, 6, 
and 11 in Hew eta/. (1988). The base pair changes at positions 79 and 99 
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1 
OP5a CGGTTTGCTT TTCGTCCTCC TTTGTGTCGA CCACATGACA 
Brain TTGTGTCGA CCACATGACA 
Blood TTGTGTCGA CCACATGACA 
Liver1 TTGTGTCGA CCACATGACA 
Liver2 TTGTGTCGA CCACATGACA 
Liver3 TTGTGTCGA CCACATGACA 
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GCCAGCCAGT CCGTGGTGGC CACCCAGCTG ATCCCCATAA 
GCCAGCCAGT CCGTGGTGGC CACCCAGCTG ATCCCCATXA 
GCCAGCCAGT CCGTGGTGGC CACCCAGCTG ATCCCCATXA 
GCCAG TCAGT CCGTGGTGGC CACCCAGCTG ATCCCCAT GA 
GCCAGCCAGT CCGTGGTGGC CACCCAGCTG ATCCCCAT GA 
GCCAGCCAGT CCGTGGTGGC CACCCAGCTG ATCCCCATAA 
81 
ATACTGCCCT GACTCCGGTG ATGATGGAGG GGAAGGTGAC 
ATACTGCCCT GACTCCGG YG ATGATGGAGG GGAAGGTGAC 
ATACTGCCCT GACTCCGG YG ATGATGGAGG GGAAGGTGAC 
ATACTGCCCT GACTCCGGCG ATGATGGAGG GGAAGGTGAC 
ATACTGCCCT GACTCCGG TG ATGATGGAGG GGAAGGTGAC 
ATACTGCCCT GACTCCGGCG ATGATGGAGG GGAAGGTGAC 
121 
CAACCCAATA GGCATCCCGT TCGCAGAGAT GTCCCAAATA 
CAACCCAATA GGCATCCCGT TCGCXGAGAT GTCCCAAATA 
CAACCCAATA GGCATCCCGT TCGCXGAGAT GTCCCAAATA 
CAACCCAATA GGCATCCCGT TCGCGGAGAT GTCCCAAATA 
CAACCCAATA GGCATCCCGT TCGCGGAGAT GTCCCAAATA 
CAACCCAATA GGCATCCCGT TCGCGGAGAT GTCCCAAATA 
161 
GTGGGGAAGC AAGTGAACAC GCCA 
GTGG 
GTGG 
GTGG 
GTGG 
GTGG 
Figure 7. Sequence consensus between the Op5a gene sequence a between 
primers OPRT-F and OPRT-R and those obtained from sequencing of PCR 
products from ocean pout blood and brain. Location of primers OPRT-F and 
OPRT-R underlined. Note: X represents adenine or guanine and Y represents 
thymine or cytosine. 
a Sequence of Op5a obtained from Hew et a/. (1988). 
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lead to amino acid changes in the mature protein while changes at positions 
46 and 145 do not. 
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3.2. Expression of the t-OP5a gene construct in transgenic Atlantic 
salmon. 
Northern blot analysis of two t-OP5a AFP transgenic Atlantic salmon 
revealed the presence of AFP mRNA in most of the tissues with the 
approximate 500 bp band being the same as that observed for the positive 
control ocean pout liver. The relative levels of AFP mRNA expression in the 
various tissues differed from that observed for the ocean pout and could be 
ranked as follows: heart, liver, stomach and brain > mouth skin , intestine, 
spleen, gill, and muscle > kidney, ovary and skin. In contrast to the ocean 
pout, no AFP mRNA was detected in blood cells (Figure 8). The internal 
control ~-actin mRNA was present in all of the salmon tissues. However 
despite the presence of AFP mRNA in the ocean pout liver, there was no 
detectable ~-actin mRNA (Figure 8). This is because the total amount of 
ocean pout liver RNA loaded on to the gel (0.01 J-Lg) was insufficient to detect 
its presence. No AFP mRNA was detected in any tissue sample from a 
control (non-transgenic) Atlantic salmon (data not shown). Once again, 
although ~-actin mRNA was present in heart and muscle, hybridization was 
also visualized at a lower position on the gel with respect to other tissues. 
RT -PCR analysis revealed that t-OP5a transgene mRNA was present 
in all tissues examined with the exception of the blood cells (Figure 9) . Also 
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Figure 8. Northern blot analysis of t-Op5a transgenic Atlantic 
salmon total RNA from various tissues as seen on a formaldehyde 
agarose gel. 1 0 f..Lg total RNA was added for each sample [0.01 f..Lg 
for ocean pout liver (positive control)]. Top panel probed for ocean 
pout OP5a AFP RNA. Middle panel probed for Atlantic salmon ~­
actin RNA. Bottom panel is RNA after electrophoresis viewed 
under ultra violet light. Lane 1 is the DIG-labeled RNA Marker I 
from Roche Applied Science in bases (60 ng used). 
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Actin ~ 
675 bp 
AFP 
184 bp ~ 
Figure 9. RT-PCR analysis of t-Op5a transgenic Atlantic salmon total 
RNA from various tissues as seen on an agarose gel. Primers were 
designed from the Atlantic salmon ~-actin gene sequence and the ocean 
pout Op5a antifreeze protein gene sequence to give a 675 bp product 
and a 184 bp product, respectively. Ocean pout Liver eDNA was used as 
a positive control. Wild Atlantic salmon testes eDNA was used as a 
negative control for the Op5a antifreeze protein gene. 
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present were faint, higher molecular weight bands (approximately 280 bp for 
all tissues with the exception of blood), and two extra faint higher molecular 
weight bands (approximately 210 and 300 bp) in ovary. All of the tissues 
tested positive for the ~-actin gene, with muscle yielding an extra, higher 
molecular weight band (approximately 800 bp). The control (non-transgenic) 
salmon testes was positive for the ~-actin mRNA and negative for the 
transgene mRNA. The ocean pout liver, which was used as a positive control , 
tested positive for both t-OP5a and ~-actin mRNA, while the water control 
tested negative for both . 
Sequence analysis of the AFP band from brain tissue that had been 
amplified by RT-PCR indicate that it was indeed derived from the OP5a AFP 
transgene. (Figure 1 0). 
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1 
OPSa CGGTTTGCTT TTCGTCCTCC TTTGTGTCGA CCACATGACA 
Brain TTGTGTCGA CCACATGACA 
41 
GCCAGCCAGT CCGTGGTGGC CACCCAGCTG ATCCCCATAA 
GCCAGCCAGT CCGTGGTGGC CACCCAGCTG ATCCCCATAA 
81 
ATACTGCCCT GACTCCGGTG ATGATGGAGG GGAAGGTGAC 
ATACTGCCCT GACTCCGGYG ATGATGGAGG GGAAGGTGAC 
121 
CAACCCAATA GGCATCCCGT TCGCAGAGAT GTCCCAAATA 
CAACCCAATA GGCATCCCGT TCGCAGAGAT GTCCCAAATA 
161 
GTGGGGAAGC AAGTGAACAC GCCA 
GTGG 
Figure 10. Sequence consensus between the OP5a gene sequence a between 
primers OPRT-F and OPRT-R and that obtained from sequencing of RT-PCR 
product from t-OP5a transgenic salmon brain . Location of primers OPRT-F 
and OPRT-R underlined. 
a Sequence of OP5a obtained from Hew et at. (1988). 
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3.3. Expression of the E0-1 a gene construct in transgenic Atlantic 
salmon. 
Northern blot analysis of tissues obtained from two E0-1 a transgenic 
Atlantic salmon demonstrated that expression of E0-1a mRNA was limited to 
the spleen and pituitary (Figure 11 ). The internal control r3-actin mRNA was 
present in most of the salmon tissues. However despite the presence of GH 
mRNA in the GH transgenic Atlantic salmon pituitary, there was no detectable 
r3-actin mRNA (Figure 11 ). This is because the total amount of pituitary RNA 
loaded on to the gel (0.6 J..Lg) was insufficient to detect its presence. Once 
again, although r3-actin mRNA was also present in heart and muscle, 
hybridization was visualized at a lower position on the gel with respect to 
other tissues. GH mRNA was not detected in any control (non-transgenic) 
Atlantic salmon tissue (data not shown) with the exception of pituitary 
(Personal communication, Madonna King, AQUA Bounty Technologies Inc., 
St. John's, Newfoundland and Labrador, Canada). 
RT-PCR analysis indicated the presence of transgene mRNA (331 bp 
band) in all tissues except blood cells (Figure 12). All non-reverse transcribed 
samples (duplicates of the reversed transcribed samples), were negative for 
transgene mRNA as was the non-transgenic and water controls (Figure 12). 
Since the E0-1 a construct contained the GH eDNA, any tissue extract that 
was contaminated by genomic DNA would have shown the same 331 bp 
band as the RT-PCR product. The absence of a 331 bp band with the non-
reverse transcribed controls eliminated this possibility. All tissues tested 
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Figure 11 . Northern blot analysis of E0-1 a transgenic Atlantic 
salmon total RNA from various tissues as seen on a formaldehyde 
agarose gel. 40 J..Lg of total RNA was added for each sample. Top 
panel probed for the E0-1 a chimeric gene construct. Middle panel 
probed for Atlantic salmon ~-actin gene. Bottom panel is RNA after 
electrophoresis viewed under ultra violet light. Lane 1 is the DIG-
labeled RNA Marker I from Roche Applied Science in bases (60 ng 
used). Lane 15 is E0-1a transgenic Atlantic salmon pituitary total 
RNA [0.6 J..Lg used (positive control)]. 
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Figure 12. RT-PCR analysis of E0-1a transgenic Atlantic salmon total 
RNA from various tissues as seen on an agarose gel (GH specific). 
Primers were designed from the chimeric gene construct containing the 
Chinook salmon growth hormone gene (opAFP-GHc2) eDNA sequence 
to give a 331 bp product. All samples were treated with DNase and 
tissue controls were not reverse transcribed. Wild Atlantic salmon testes 
was used as a negative control while the opAFP-GHc2 construct in 
pUC 19 was used as a positive control. 
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positive for the salmon ~-actin mRNA in both the transgenic and control 
salmon tissues with muscle yielding an extra, higher molecular weight band 
(approximately 800 bp). The water control tested negative (Figure 13). 
Sequence 
Analysis of the GH bands from muscle and spleen that had been 
amplified by RT-PCR indicated that they were derived from a type Ill AFP 
gene (Figure 14). 
3.4. Thermal hysteresis 
Thermal hysteresis (TH) measurements were taken on blood plasma 
samples from ocean pout and both lines of transgenic Atlantic salmon (t-
OP5a and E0-1a) (Table 3). Samples from two ocean pout had an average 
TH of 1.355 °C and showed bipyrimidal ice crystal shaping typical of a high 
concentration of AFP (Figure 15). On the other hand, samples from six t-
OP5a transgenic Atlantic salmon had an average TH of 0.019 °C and 
exhibited hexagonal ice crystal shaping indicative of the presence of a low 
concentration of AFP (Figure 16). Finally, samples from two E0-1a transgenic 
Atlantic salmon displayed no TH and no ice crystal shaping and therefore 
served as negative controls (Figure 17). 
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675bp ~ 
Figure 13. RT-PCR analysis of E0-1a transgenic Atlantic salmon total RNA 
from various tissues as seen on an agarose gel (Actin control). Primers were 
designed from the Atlantic salmon p-actin gene sequence to give a 675 bp 
product. Wild Atlantic salmon testes was used as a positive control. 
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1 
OpAFP - GHc2 GTCAGAAGTC TCAGCTACAG CTTTCACTTC GATCCAGATC 
Muscle TTTCACTTC GATCCAGATC 
Spleen TTTCACTTC GATCCAGATC 
41 
TTTTCACTTC GATCTCCGAT AATTAATTAA TTAATTAATT 
TTTTCACTTC GATCTCCGAT AATTAATTAA TTAATTAATT 
TTTTCACTTC GATCTCCGAT AATTAATTAA TTAATTAATT 
81 
ATTAATTAAT TAAGTCTCAG CCACTGCAGG TCGTAAAAAT 
ATTAATTAAT TAAGTCTCAG CCACTGCAGG TCGTAAAAAT 
ATTAATTAAT TAAGTCTCAG CCACTGCAGG TCGTAAAAAT 
121 
GGGACAAGTG TTTCTGCTGA TGCCAGTCTT ACTGGTCAGT 
GGGACAAGTG TTTCTGCTGA TGCCAGTCTT ACTGGTCAGT 
GGGACAAGTG TTTCTGCTGA TGCCAGTCTT ACTGGTCAGT 
161 
TGTTTCCTGA GTCAAGGGGC AGCGATAGAA AACCAACGGC 
TGTTTCCTGA GTCAAGGGGC AGCGATAGAA AACCAACGGC 
TGTTTCCTGA GTCAAGGGGC AGCGATAGAA AACCAACGGC 
201 
TCTTCAACAT CGCGGTCAGC CGGGTGCAAC ATCTCCACCT 
TCTTCAACAT CGCGGTCAGC CGGGTGCAAC ATCTCCACCT 
TCTTCAACAT CGCGGTCAGC CGGGTGCAAC ATCTCCACCT 
241 
ATTGGCTCAG AAAATGTTCA ATGACTTTGA CGGTACCCTG 
ATTGGCTCAG AAAATGTTCA ATGACTTTGA CGGTACCCTG 
ATTGGCTCAG AAAATGTTCA ATGACTTTGA CGGTACCCTG 
281 
TTGCCTGATG AACGCAGACA GCTGAACAAG ATATTCCTGC 
TTGCCTGATG AACGCAGACA GCTGAACAAG 
TTGCCTGATG AACGCAGACA GCTGAACAAG 
321 
TGGACTTCTG T 
Figure 14. Sequence consensus between the opAFP-GHc2 gene construct 
sequencea between primers A-F and D-R and those obtained from 
sequencing of PCR products from E0-1a transgenic Atlantic salmon muscle 
and spleen. Locations of primers A-F and D-R underlined. 
a Sequence of opAFP-GHc2 obtained from Hew eta/. (1989) ; Duet a/. 
(1992b) ; Personal communication , Madonna King , AQUA Bounty 
Technologies Inc. , St. John's, Newfoundland and Labrador, Canada. 
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Table 3. Plasma thermal hysteresis measurements taken from ocean pout 
and transgenic Atlantic salmon. 
Sample Melting Freezing Average Average Thermal 
(Fish#) Point Point Melting Point Freezing Point Hysteresis (TH) 
(mOsmols) (mOsmols) (AvMP) (AvFP) (OC) 
(mOsmols) (mOsmols) 
Ocean 520 1280 
Pout #1 520 1270 523.3 1276.7 1.40 
530 1280 
Ocean 420 1120 
Pout#2 420 1130 420 1126.7 1.31 
420 1130 
BS 3009 400 410 
(t-OP5a 380 390 396.7 406.7 0.019 
salmon) 410 420 
BS 3033 425 435 
(t-OP5a 420 430 421.7 431.7 0.019 
salmon) 420 430 
BS 3073 395 405 
(t-OP5a 415 425 406.7 416.7 0.019 
salmon) 410 420 
BS 3018 385 395 
(t-OP5a 375 385 378.3 388.3 0.019 
salmon) 375 385 
BS 3065 380 390 
(t-OP5a 390 400 386.7 396.7 0.019 
salmon) 385 395 
BS 2956 410 420 
(t-OP5a 390 400 396.7 406.7 0.019 
salmon) 390 400 
990456 360 360 
t-(opAFP- 390 390 383.3 383.3 0 
GHc2 400 400 
salmon) 
990371 405 405 
(t-opAFP- 370 370 386.6 386.6 0 
GHc2 385 385 
salmon) 
Thermal hysteresis was calculated using the following formula (Kao eta/. 
1986): 
TH (°C) = AvFP- AvMP x 1.858 
1000 
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Figure 15. Ice crystal from ocean pout blood plasma illustrating 
bipyrimidal shaping due to the presence of a high concentration of 
AFP (320x magnification). 
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Figure 16. Ice crystal from t-Op5a transgenic Atlantic salmon BS 3009 
blood plasma illustrating hexagonal shaping due to the presence of a 
low concentration of AFP (320 x magnification) . 
52 
Figure 17. Ice crystal from E0-1 a transgenic Atlantic salmon 
990456 blood plasma illustrating no shaping due to the absence of 
AFP (320 x magnification). 
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4. Discussion 
The OP5a AFP gene examined in this study was isolated from a 
Charon 30 genomic library of Newfoundland and Labrador ocean pout DNA. 
Although sequence analysis revealed that it did not code for any of the AFP 
purified from plasma it had all of the elements associated with a fully 
functional gene (Hew eta/. 1988). A number of studies have demonstrated 
that the OP5a AFP promoter is indeed fully functional and capable of driving 
gene expression. Initial studies by Gong and Hew (1993) and more recently 
by Kirby (2005) have shown that the promoter was able to drive expression of 
chloramphenicol acetyltransferase (CAT) and luciferase reporter genes in a 
variety of fish and mammalian cell lines. These studies also demonstrated 
the presence of positive and negative regulatory elements within the promoter 
that would enable modulation of gene expression in a cell specific manner. 
The greatly enhanced growth rates of several fish species transgenic for 
chimeric growth hormone gene constructs driven by the OP5a AFP promoter 
also provides direct evidence for its ability to function in vivo (Du eta/. 1992a, 
Devlin eta/. 1995, Maclean eta/. 2002). 
In general the promoter region of a gene contains elements that direct 
tissue specific expression (von Hippel eta/. 1982; de Freitas eta/. 1994; 
Dynan and Tjian, 1985). Therefore, although the preceding studies 
demonstrate the functionality of the OP5a promoter in vitro they do not 
provide any information as to whether or not it contains tissue specific 
elements. The availability of stable lines of salmon transgenic for either 
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growth hormone or type Ill AFP both driven by modified OP5a AFP promoters 
provided a unique opportunity to examine the tissue specific expression of 
two different genes in vivo and compare their expression patterns with those 
observed in the ocean pout. 
The results of northern blot analyses of ocean pout tissues confirmed 
conclusions by Gong eta/. (1992) that the AFP genes in this species are 
expressed in most tissues, with levels ranging from the highest values in liver 
to barely detectable levels in brain and blood, and no expression in muscle 
(Figure 4). Further analysis using the more sensitive RT-PCR procedure 
(Foley eta/. 1993; Mocharla eta/. 1990) revealed that low levels of AFP 
mRNA transcripts were also present in the muscle tissue. Since the ocean 
pout has approximately 1 00-150 copies of homologous AFP genes, it was not 
possible to determine which genes were responsible for the observed 
expression patterns. It was also not possible to determine whether the OP5a 
AFP gene was being expressed in any or all of the tissues. Sequence 
analysis of the PCR am pi icons from liver, blood and brain tissue (Figure 7) 
clearly indicates that they were the products of a number of different AFP 
genes whose nucleotide or amino acid sequences are identified in Hew et a/. 
(1988) . 
The RT -PCR results showing transgene expression in all tissues 
except blood cells from the t-OP5a and E0-1 a transgenics suggests that the 
OP5a AFP gene lacks tissue specific elements. Since the ocean pout 
expresses a large number of highly homologous AFP (Hew eta/. 1988), it is 
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likely that the expression observed for the ocean pout blood cells is 
attributable the expression of an AFP gene other than OP5a. An alternative 
explanation is that Atlantic salmon blood cells lack the transcriptional factors 
needed for AFP expression that ocean pout blood cells express. These 
hypotheses can only be tested by further analysis of the ocean pout blood cell 
expression products. 
Two aspects of AFP gene, and AFP promoter driven GH expression, 
as determined by northern analysis, differed between the ocean pout and the 
two lines of transgenic salmon; a) overall levels of expression and b) relative 
tissue specific expression patterns. The high levels of expression in the 
ocean pout tissues compared with those observed for the transgenic salmon 
is likely attributable to the large number of AFP genes expressed by the 
ocean pout. This argument is supported by sequence analysis of PCR 
amplicons from the ocean pout liver showing the presence of a number of 
different gene products (Figure 7). In addition, AFP gene dosage has been 
shown to be positively correlated with blood plasma AFP levels. For example 
ocean pout from Newfoundland have approximately ten times the plasma 
levels of AFP, and three to four times the number of AFP genes observed in 
New Brunswick ocean pout (Fletcher eta/. 1985; Hew eta/. 1988). Duncker et 
a/. (1999) demonstrated with the use of a model transgenic host, the fruit fly 
Drosophilia melanogaster, that increased gene dosage can increase the 
production of type Ill AFP. The very low levels of expression observed in the 
E0-1a transgenic salmon which has only a single copy of the transgene also 
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lends support to the hypothesis that the level of expression can depend, at 
least in part, on the number of functional gene copies. Although the number of 
transgene copies present in the t-OP5a transgenic salmon is unknown it 
would appear from the trace amounts of AFP activity found in the plasma 
(Figure 16) that the gene copy number is low. 
Another factor that could have played a role in the relatively low levels 
of expression in the transgenic salmon is the fact that in both cases the 
OP5a gene promoter was considerably truncated (Figures 2 and 4) (Wu 
1994, Kirby 2005, Unpublished data, Ed Yaskowiak, AQUA Bounty 
Technologies Inc., St. John's, Newfoundland and Labrador, Canada). 
Promoter analysis has revealed that although these truncated promoters are 
equally functional, their ability to drive the expression of reporter genes in fish 
and mammalian cell lines was reduced to approximately a third the activity of 
the full length promoter (Gong and Hew 1993, Kirby 2005) . These results 
indicated that the 5' end of the promoter that was removed contained 
enhancer elements. However in a recent promoter analysis study Kirby 
(2005) found that locating this 5' promoter section downstream of the 3' 
flanking region, as it is in the E0-1a GH transgenic salmon (Figure 17) 
restored little if any of the lost promoter strength, indicating possible 
directionality of the enhancer region. 
Once again, the possibility exists that Atlantic salmon transcriptional 
factors are slightly different in sequence and therefore do not bind to ocean 
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pout promoters as well as ocean pout transcriptional factors, resulting in 
diminished expression levels. 
The lower levels of expression in the E0-1 a transgenic salmon as 
compared with those observed for the t-OP5a AFP transgenics could be 
attributable to the lack of introns in the E0-1 a transgene. It is evident that 
introns can be essential if high levels of expression are desirable. Studies by 
Brinster eta/. (1988) demonstrated, using the transgenic mouse model, that 
the presence of introns increased transcriptional efficiency. Palmiter eta/. 
(1991) followed this study up by showing that the addition of heterologous 
introns between the metallothionein promoter and a growth hormone gene 
improved expression in transgenic mice. Similarly Duncker eta/. (1997) 
demonstrated that introns boosted type Ill AFP gene expression in transgenic 
Drosophilia. 
Despite the fact that the genes being examined were all driven by the 
same or a very similar AFP gene promoter the relative tissue specific 
expression patterns differed considerably between the three groups of fish. 
For example expression levels in ocean pout liver were at least 10 times 
greater than any of the other tissues examined (Figure 5, Gong eta/. 1992). 
In contrast the level of expression in liver tissue obtained from t-OP5a AFP 
transgenic salmon did not differ appreciably from that observed for heart or 
brain; tissues that showed very low levels of expression in the ocean pout 
(Figures 5 and 8) . In E0-1a GH transgenic salmon, the spleen was the only 
tissue that showed evidence for transgene expression using northern blot 
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analysis. Although the pituitary showed high levels of expression in these 
salmon, it is likely that the probe used for northern analysis was hybridizing to 
mRNA expressed by the endogenous GH genes as control non-transgenic 
salmon show a similar degree of hybridization (Personal communication, 
Madonna King , AQUA Bounty Technologies Inc. , St. John's, Newfoundland 
and Labrador, Canada). 
Some possible reasons for the observed differences in tissue specific 
expression between the fish groups studied could be related to species 
differences in their molecular capacity to transcribe AFP genes, the specific 
AFP gene under study (OP5a), and in the case of the transgenic fish, the 
intactness of the promoter and presence or absence of introns. 
The relatively equitable expression levels of the AFP gene across a 
wide range of tissues in the t-OP5a AFP transgenic salmon clearly indicates 
that the OP5a AFP gene with its truncated promoter (Figure 2) has little or no 
tissue specificity. Since AFP are predominantly expressed in the ocean pout 
liver, the question arises as to whether the 5' region that was removed from 
the OP5a promoter contained liver specific elements. Although this is a 
possibility, there are several reasons to think that this may not be the case. 
The fact that the OP5a AFP gene does not code for any of the known plasma 
AFP suggests that at best it plays a minor role in AFP production by the liver. 
In addition the sequences obtained for the PCR amplicons from the ocean 
pout liver tissue did not correspond to the OP5a AFP gene but rather to 
several of the major AFP found in blood plasma (Figure 7) . Furthermore the 
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presence of the 5' region of the OP5a AFP promoter at the 3' end of the E0-
1 a GH transgene (Figure 4) in the E0-1 a line of transgenic salmon did not 
result in any significant liver expression (Figure 11 ). Based on the foregoing 
discussion, it seems that the predominance of liver AFP gene expression in 
the ocean pout must be attributable to AFP genes other than OP5a that have 
a high degree of liver specificity. 
Studies by Miao eta/. (1998a, 1998b, 2000) demonstrated that introns 
can play an important role in determining the tissue specificity of gene 
expression. These authors found that the intron in the winter flounder type I 
AFP genes not only possessed enhancer elements, it also dictated whether 
expression was relatively ubiquitous, as is the case for the skin type I AFP, or 
strictly liver specific. Since expression of the AFP gene in the t-OP5a 
transgenic salmon showed no significant tissue specificity it seems 
reasonable to conclude that unlike the winter flounder liver type AFP, the 
introns within the OP5a AFP gene do not contain tissue specific elements, or 
that salmon lack the factors needed to recognize them. This would suggest 
that the high degree of liver specific expression in the ocean pout must be 
encoded within one or more of the AFP genes that code for the AFP found in 
abundance in the blood plasma of this species. 
The reason for the difference in tissue specific expression patterns 
between the t-OP5a AFP and the E0-1a transgenics is unknown. The low 
levels of expression in the E0-1 a transgenics compared with those observed 
for the t-OP5a transgenics could be accounted for by the lack of introns. 
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However the considerable reduction in expression levels observed in heart, 
liver stomach and brain, etc., relative to the spleen suggests that the introns 
within the OP5a AFP gene may in some way be responsible for these 
differences between the two transgenic lines. 
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